Brain-derived neurotrophic factor and antidepressant activity

Current Pharmaceutical Design

Volumn 11, Issue 12, 2005, Pages 1495-1510

  Russo Neustadt, A A ^a   Chen, M J ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMPA RECEPTOR AGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CLONIDINE; DIZOCILPINE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMIPRAMINE; KETANSERIN; LITHIUM; MAPROTILINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOAMINE OXIDASE INHIBITOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NEUROTROPHIN; NORADRENALIN; OLANZAPINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROPRANOLOL; REBOXETINE; ROLIPRAM; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRANSCRIPTION FACTOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

BEHAVIOR DISORDER; BRAIN NERVE CELL; BRAIN REGION; CELL SURVIVAL; CHRONIC DISEASE; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; GABAERGIC SYSTEM; HUMAN; LEARNING; LONG TERM POTENTIATION; MOLECULAR MECHANICS; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; STRESS; TISSUE DISTRIBUTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; EXERCISE; GENE EXPRESSION REGULATION; HUMANS; NEURONAL PLASTICITY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, GABA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 18844460905     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612053764788     Document Type: Review

References (281)

1. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
2. Popoli M, Brunello N, Perez J, Racagni, G. Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs. J Neurochem 2000; 74: 21-33.
3. Shelton RC. Cellular mechanisms in the vulnerability to depression and response to antidepressants. Psychiatr Clin North Am 2000; 23: 713-29.
4. Lewin, GR, Barde, YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996; 19: 289-317.
5. Black, IB. Trophic regulation of synaptic plasticity. J Neurobiol 1999; 41: 108-18.
6. Gomez-Pinilla F, Ying Z, Roy RR, Molteni R, Edgerton VR. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol 2002; 88: 2187-95.
7. Gorski JA, Zeiler SR, Tamowski S, Jones KR. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 2003; 23: 6856-65.
8. Lu B, Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 1999; 58: 76-87.
9. McAllister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci, 1999; 22:295-318.
10. Russo-Neustadt A. Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders. Semin Clin Neuropsychiatry 2003; 8: 109-18.
11. Yamada K, Mizuno M, Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci 2002; 70: 735-44.
12. Dreyfus, CF. Neurotransmitters and neurotrophins collaborate to influence brain development. Perspect Dev Neurobiol 1998; 5: 389-99.
13. Tucker KL, Meyer M, Barde YA. Neurotrophins are required for nerve growth during development. Nat Neurosci 2001; 4: 29-37.
14. Fu W, Lu C, Mattson MP. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J Neurosci 2002; 22: 10710-9.
15. Hetman M, Kanning K, Cavanaugh JE Xia, Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 1999; 274: 22569-80.
16. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000; 20: 5775-81.
17. Lee R, Kermani P, Teng KK, Hempstead, BL. Regulation of cell survival by secreted proneurotrophins. Science 2001; 294: 1945-8.
18. Bunney WE Jr, Davis JM. Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry 1965; 13: 483-94.
19. Delgado PL, Moreno FA. Role of norepinephrine in depression. J Clin Psychiatry 2000; 61 Suppl 1: 5-12.
20. Neumeister A, Konstantinidis A, Praschak-Rieder N, Willeit, M, Hilger, E, Stastny, J, et al. Monoaminergic function in the pathogenesis of seasonal affective disorder. Int J Neuropsychopharmacol 2001; 4: 409-20.
21. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122: 509-22.
22. Vaidya VA, Duman RS. Depresssion - emerging insights from neurobiology. Br Med Bull 2001; 57: 61-79.
23. Leonard BE. Evidence for a biochemical lesion in depression. J Clin Psychiatry, 2000; 61 Suppl 6: 12-7.
24. Katz MM, Tekell JL, Bowden CL, Brannan S, Houston JP, Berman N, et al. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 2004; 29: 566-79.
25. Nakayama AY, Luo L. Intracellular signaling pathways that regulate dendritic spine morphogenesis. Hippocampus 2000; 10: 582-6.
26. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20:9104-10.
27. D'Sa, C, Duman, RS. Antidepressants and neuroplasticity. Bipolar Disord 2002; 4: 183-94.
28. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990; 47:1038-47.
29. Biegon A, Israeli M. Regionally selective increases in beta-adrenergic receptor density in the brains of suicide victims. Brain Res 1988; 442: 199-203.
30. Mann JJ, Stanley M, McBride PA, McEwen BS. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986; 43: 954-9.
31. Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch Gen Psychiatry 1989; 46: 237-41.
32. De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW. Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res 1990; 525: 71-7.
33. De Paermentier F, Crompton MR, Katona CL, Horton RW. beta-adrenoceptors in brain and pineal from depressed suicide victims. Pharmacol Toxicol 1992; 71 Suppl 1: 86-95.
34. Little KY, Ranc J, Gilmore J, Patel A, Clark TB. Lack of pineal beta-adrenergic receptor alterations in suicide victims with major depression. Psychoneuroendocrinology 1997; 22: 53-62.
35. Sastre M, Guimon, J, Garcia-Sevilla JA. Relationships between beta- and alpha2-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide. Brain Res 2001; 898: 242-55.
36. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman, JE. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry 1993; 50: 810-8.
37. Papp M, Klimek V, Willner P. Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology (Berl) 1994; 114: 309-14.
38. Pandey SC, Ren X, Sagen J, Pandey GN. Beta-adrenergic receptor subtypes in stress-induced behavioral depression. Pharmacol Biochem Behav 1995; 51: 339-44.
39. Anand A, Charney DS. Norepinephrine dysfunction in depression. J Clin Psychiatry 2000; 61 Suppl 10: 16-24.
40. Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment, Implications for the etiology and therapy of depression. Arch Gen Psychiatry 1981; 38: 1160-80.
41. De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW. Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment. Psychopharmacology (Berl) 1991; 105: 283-8.
42. Harkin A, Nally R, Kelly JP, Leonard BE. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression. J Neural Transm 2000; 107: 1213-27.
43. Karolewicz B, Bruce KH, Lee B Paul IA. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in downregulation of cortical beta-adrenoceptors. Eur J Pharmacol 1999; 372: 215-20.
44. Vetulani S, Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyctic AMP-generating system in limbic forebrain. Nature 1975; 257: 495-496.
45. Donati RJ, Rasenick MM. G protein signaling and the molecular basis of antidepressant action. Life Sci 2003; 73: 1-17.
46. Duman RS. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998; 44: 324-35.
47. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46:1181-91.
48. Duman RS, Nakagawa S, Malberg J. Regulation of adult neuro-genesis by antidepressant treatment. Neuropsychopharmacology 2001; 25: 836-44.
49. Amsterdam JD, Maislin G, Skolnick B, Berwish N, Winokur A. Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers. Biol Psychiatry 1989; 26: 265-78.
50. Checkley SA, Slade AP, Shur E. Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 1981; 138: 51-5.
51. Katona, CL, Healy, D, Paykel, ES, Theodorou, AE, Lawrence, KM, Whitehouse, A, et al. Growth hormone and physiological responses to clonidine in depression. Psychol Med 1993; 23: 57-63.
52. Meana JJ, Barturen F, Garcia-Sevilla JA. Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry 1992; 31: 471-90.
53. Ordway GA, Widdowson PS, Smith KS, Halaris A. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neurochem 1994; 63: 617-24.
54. Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, Garcia-Sevilla JA. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem 1998; 70:1114-23.
55. Barturen F, Garcia-Sevilla JA. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain. Mol Pharmacol 1992; 42: 846-55.
56. Gurguis GN, Blakeley JE, Antai-Otong D, Vo SP, Orsulak PJ, Petty F, et al. Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome. J Psychiatr Res 1999; 33: 309-22.
57. Vizi ES, Kiss JP. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus 1998; 8: 566-607.
58. Manji HK, Quiroz JA, Spom J, Payne JL, Denicoff K, N, AG, et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003; 53: 707-42.
59. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry 2000; 48:721-31.
60. McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999; 22: 105-22.
61. Smith MA. Hippocampal vulnerability to stress and aging: possible role of neurotrophic factors. Behav Brain Res 1996; 78: 25-36.
62. Bowman RE, Zrull MC, Luine VN. Chronic restraint stress enhances radial arm maze performance in female rats. Brain Res 2001; 904: 279-89.
63. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 1999; 2: 260-5.
64. Sandi C. The role and mechanisms of action of glucocorticoid involvement in memory storage. Neural Plast 1998; 6: 41-52.
65. Popoli M, Gennarelli M, Racagni G. Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord 2002; 4: 166-82.
66. Harvey BH, Jonker LP, Brand L, Heenop M, Stein DJ. NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus. Life Sci 2002; 71: 43-54.
67. Krystal JH, Sanacora G, Blumberg, H, Anand A, Chamey DS, Marek, G et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002; 7 Suppl 1: S71-80.
68. Paul IA. Antidepressant activity and calcium signaling cascades. Hum Psychopharmacol 2001; 16:71-80.
69. Toronen P, Storvik M, Linden AM, Kontkane O, Marvanova M, Lakso M, et al. Expression profiling to understand actions of NMDA/glutamate receptor antagonists in rat brain. Neurochem Res 2002; 27: 1209-20.
70. Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 1995; 675:157-64.
71. Holemans S, De Paermentier F, Horton RW, Crompton MR, Katona CL, Maloteaux, JM. NMDA glutamatergic receptors, labelled with 3HMK-801, in brain samples from drug-free depressed suicides. Brain Res 1993; 616: 138-43.
72. Gereau RWt, Winder DG, Conn PJ. Pharmacological differentiation of the effects of co-activation of beta-adrenergic and metabotropic glutamate receptors in rat hippocampus. Neurosci Lett 1995; 186:119-22.
73. Paul IA, Trullas R, Skolnick P, Nowak G. Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists. Psychopharmacology (Berl) 1992; 106: 285-7.
74. Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 1996; 29: 23-6.
75. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003; 8: 721-37, 715.
76. Shiah IS, Yatham LN. GABA function in mood disorders: an update and critical review. Life Sci 1998; 63: 1289-303.
77. Tunnicliff G, Malatynska E. Central GABAergic systems and depressive illness. Neurochem Res 2003; 28: 965-76.
78. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003; 160: 577-9.
79. Freund TF, Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996; 6: 347-470.
80. Baldelli P, Novara M, Carabelli V, Hernandez-Guijo JM, Carbone E. BDNF up-regulates evoked GABAergic transmission in developing hippocampus by potentiating presynaptic N- and P/Q-type Ca2+ channels signalling. Eur J Neurosci 2002; 16: 2297-310.
81. Robinson RT, Drafts BC, Fisher JL. Fluoxetine increases GABA(A) receptor activity through a novel modulatory site. J Pharmacol Exp Ther 2003; 304: 978-84.
82. Herman JP, Renda A, Bodie B. Norepinephrine-gamma-aminobutyric acid (GABA) interaction in limbic stress circuits: effects of reboxetine on GABAergic neurons. Biol Psychiatry 2003; 53: 166-74.
83. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999-1010.
84. Bliss EL, Ailion J, Zwanziger J. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress. J Pharmacol Exp Ther 1968; 164: 122-34.
85. Kitayama l, Yaga T, Kayahara T, Nakano K, Murase S, Otani M, et al. Long-term stress degenerates, bur imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biol Psychiatry 1997; 42: 687-96.
86. Kvetnansky R, Palkovits M, Mitro A, Torda T, Mikulaj L. Catecholamines in individual hypothalamic nuclei of acutely and repeatedly stressed rats. Neuroendocrinology 1977; 23: 257-67.
87. Stone EA, Manavalan SJ, Zhang Y, Quartermain D. Beta adrenoceptor blockade mimics effects of stress on motor activity in mice. Neuropsychopharmacology 1995; 12: 65-71.
88. Lynch M, Littleton J, McKernan RM, Durcan MJ, McMillan T, Campbell IC. Alpha-adrenoceptor number and function in rat cortex after ethanol and immobilization stress. Brain Res 1983; 288: 145-9.
89. Gould E, Tanapat P, McEwen BS, Flugge G, Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 1998; 95: 3168-71.
90. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002; 22:6810-8.
91. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925-35.
92. Watanabe Y, Gould E, McEwen BS. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res 1992; 588: 341-5.
93. Mizoguchi K, Kunishita T, Chui DH, Tabira T. Stress induces neuronal death in the hippocampus of castrated rats. Neurosci Lett 1992; 138: 157-60.
94. Smith MA, Makino S, Kvetnansky R, Post RM Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995; 15: 1768-77.
95. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Tone S, Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 1997; 28: 103-10.
96. Vaidya VA, Marek GJ, Aghajanian GK, Duman RS. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 1997; 17: 2785-95.
97. Russo-Neustadt A, Ha T, Ramirez, R, Kesslak JP. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001; 120: 87-95.
98. Bianchi M, Heidbreder C, Crespi F. Cytoskeletal changes in the bippocampus following restraint stress: role of serotonin and microtubules. Synapse 2003; 49:188-94.
99. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157:115-8.
100. Lopez JF, Chalmers DT, Little KY, Watson SJ. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998; 43: 547-73.
101. Homer HC, Packan DR, Sapolsky RM. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 1990; 52: 57-64.
102. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77:169-84.
103. Kume T, Kouchiyama H, Kaneko S, Maeda T, Akaike A, Shimohama S, et al. BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons. Brain Res 1997; 756: 200-4.
104. Hagerty T, Fernandez E, Lynch K, Wang SS, Morgan WW, Strong R. Interaction of a glucocorticoid-responsive element with regulatory sequences in the promoter region of the mouse tyrosine hydroxylase gene. J Neurochem 2001; 78: 1379-88.
105. Hagerty T, Morgan WW, Elango N, Strong R. Identification of a glucocorticoid-responsive element in the promoter region of the mouse tyrosine hydroxylase gene. J Neurochem 2001; 76: 825-34.
106. Pruett SB, Fan R, Zheng Q. Characterization of glucocorticoid receptor translocation, cytoplasmic IkappaB, nuclear NFkappaB, and activation of NFkappaB in T lymphocytes exposed to stress-inducible concentrations of corticosterone in vivo. Int Immunopharmacol 2003; 3: 1-16.
107. Molteni R, Bamard RJ, Ying Z, Roberts CK, Gomez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002; 112: 803-14.
108. Wu A, Molteni R, Ying Z, Gomez-Pinilla F. A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience 2003; 119: 365-75.
109. Mattson MP. Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res 2000; 886: 47-53.
110. Mattson MP, Duan W, Maswood N. How does the brain control lifespan? Ageing Res Rev 2002; l: 155-65.
111. Mattson MP, Duan W, Guo Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J Neurochem 2003; 84:417-31.
112. Ballmaier M, Sowell ER, Thompson PM, Kumar A, Narr KL, Lavretsky H, et al. Mapping brain size and cortical gray matter changes in elderly depression. Biol Psychiatry 2004; 55: 382-9.
113. Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004; 161: 99-108.
114. Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002; 51: 273-9.
115. Lacerda AL, Keshavan MS, Hardan AY, Yorbik O, Brambilla P, Sassi RB, et al. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry 2004; 55: 353-8.
116. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-98.
117. Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann, JJ. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004; 29: 952-9.
118. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-5.
119. Shah PJ, Ebmeier KP, Glabus MF; Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 1998; 172: 527-32.
120. Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, et al. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 2003; 124: 129-40.
121. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000; 48: 766-77.
122. Bowley MP, Drevets WC, Ongur D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-12.
123. Chana G, Landau S, Beasley C, Everall IP, Cotter D. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 2003; 53: 1086-98.
124. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002; 12: 386-94.
125. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58: 545-53.
126. Miguel-Hidalgo JJ, Wei J, Andrew M, Overholser JC, Jurjus G, Stockmeier CA, et al. Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry 2002; 52:1121-33.
127. Drevets WC, Ongur D, Price JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology offamilial mood disorders. Mol Psychiatry 1998; 3: 220-6, 190-1.
128. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-5.
129. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 2002; 22: 3262-8.
130. Coppell AL, Pei Q, Zetterstrom TS. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 2003; 44: 903-10.
131. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic etectroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-47.
132. Okamoto H, Shino Y, Hashimoto K, Kumakiri C, Shimizu E, Shirasawa H, et al. Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor. Neuropharmacology 2003; 45:251-9.
133. Russo-Neustadt A, Beard RC, Cotman CW. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 1999; 21: 679-82.
134. Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000; 101: 305-12.
135. Xu H, Steven Richardson J, Li XM. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 2003; 28: 53-62.
136. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-5.
137. Altar CA. Neurotrophins and depression. Trends Pharmacol Sci 1999; 20: 59-61.
138. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22: 3251-61.
139. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56:131-7.
140. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDónald E, et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci, 2003; 23: 349-57.
141. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003; 23:7311-6.
142. Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995; 15: 7929-39.
143. Sklair-Tavron L, Nestler EJ. Opposing effects of morphine and the neurotrophins, NT-3, NT-4, and BDNF, on locus coeruleus neurons in vitro. Brain Res 1995; 702: 117-25.
144. Nottebohm F. Why are some neurons replaced in adult brain? J Neurosci 2002; 22: 624-8.
145. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407: 802-9.
146. Levine ES, Dreyfus CF, Black IB, Plummer MR. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc Natl Acad Sci USA 1995; 92: 8074-7.
147. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996; 381: 706-9.
148. Ikegaya Y, Ishizaka Y, Matsuki N. BDNF attenuates hippocampal LTD via activation of phospholipase C: implications for a vertical shift in the frequency-response curve of synaptic plasticity. Eur J Neurosci 2002; 16: 145-8.
149. Kang H, Schuman EM. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995; 267: 1658-62.
150. Scharfman HE. Hyperexcitability in combined entorhinal/ hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor. J Neurophysiol 1997; 78: 1082-95.
151. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995; 92: 8856-60.
152. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996; 16: 1137-45.
153. Coffey ET, Akerman KE, Courtney MJ. Brain derived neurotrophic factor induces a rapid upregulation of synaptophysin and tau proteins via the neurotrophin receptor TrkB in rat cerebellar granule cells. Neurosci Lett 1997; 227: 177-80.
154. Takei N, Sasaoka K, Inoue K, Takahashi M, Endo Y, Hatanaka H. Brain-derived neurotrophic factor increases the stimulation-evoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats. J Neurochem 1997; 68: 370-5.
155. Pozzo-Miller LD, Gottschalk W, Zhang L, McDermott K, Du J, Gopalakrishnan R, et al. Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci 1999; 19: 4972-83.
156. Tyler WJ, Pozzo-Miller LD. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci 2001; 21: 4249-58.
157. Tartaglia N, Du J, Tyler WJ, Neale E, Pozzo-Miller L, Lu B. Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor. J Biol Chem 2001; 276: 37585-93.
158. Mazer C, Muneyyirci J, Taheny K, Raio N, Borella A, Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res 1997; 760: 68-73.
159. D'Onofrio M, Cuomo L, Battaglia G, Ngomba RT, Storto M, Kingston AE, et al. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem 2001; 78: 435-45.
160. Magarinos AM, Destandes A, McEwen BS. Effects of antidep:essants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999; 371: 113-22.
161. van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyms. Nat Neurosci 1999; 2: 266-70.
162. Young D, Lawlor PA, Leone P, Dragunow M, During MJ. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 1999; 5: 448-53.
163. Goldman SA. Adult neurogenesis: from canaries to the clinic. J Neurobiol 1998; 36: 267-86.
164. Benraiss A, Chmielnicki E, Lerner K, Roh D, Goldman SA Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci 2001; 21: 6718-31.
165. Pencea V, Bingaman KD, Wiegand SJ, Luskin MB. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septuni, thalamus, and hypothalamus. J Neurosci 2001; 21: 6706-17.
166. Katoh-Semba R, Asano T, Ueda H, Morishita R, Takeuchi IK, Inaguma Y, et al. Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 2002; 16: 1328-30.
167. Song HJ, Stevens CF, Gage FH. Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat Neurosci 2002; 5: 438-45.
168. Ma YL, Wang HL, Wu HC, Wei CL, Lee EH. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits Iong-term potentiation in rats. Neuroscience 1998; 82: 957-67.
169. Voilmayr B, Simonis C, Weber S, Gass P, Henn F. Redueed cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 2003; 54: 1035-40.
170. Horch HW, Kruttgen A, Portbury SD, Katz LC. Destabilization of cortical dendrites and spines by BDNF. Neuron 1999; 23: 353-64.
171. Aakalu G, Smith W, Nguyen N, Jiang C, Schuman E. Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron 2002; 30: 489-502.
172. Boatell LL, Lindefors N, Ballarin M, Ernfors P, Mahy N, Persson H. Activation of basal forebrain cholinergic neurons differentially regulates brain-derived neurotrophic factor mRNA expression in different projection areas. Neurosci Lett 1992; 136: 203-8.
173. Gall CM. Seizure-induced changes in neurotrophin expression: implications for epilepsy. Exp Neurol 1993; 124: 150-66.
174. Gwag BJ, Springer JE. Activation of NMDA receptors increases brain-derived neurotrophic factor (BDNF) mRNA expression in the hippocampal formation. Neuroreport 1993; 5: 125-8.
175. Rocamora N, Welker E, Pascual M, Soriano E. Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation. J Neurosci 1996; 16:4411-9.
176. Schoups AA, Elliott RC, Friedman WJ, Black IB. NGF and BDNF are differentially modulated by visual experience in the developing geniculocortical pathway. Brain Res Dev Brain Res 1995; 86: 326-34.
177. Castren E, Beminger B, Leingartner A, Lindholm D. Regulation
178. Li XC, Jarvis ED, Alvarez-Borda B, Lim DA, Nottebohm F. A relationship between behavior, neurotrophin expression, and new neuron survival. Proc Natl Acad Sci USA 2000; 97: 8584-9.
179. Liu D, Diorio J, Day JC, Francis DD, Meaney MJ. Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat Neurosci 2000; 3: 799-806.
180. van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci 2000; 1: 191-8.
181. Falkenberg T, Mohammed AK, Henriksson B, Persson H, Winblad B, Lindefors N. Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett 1992; 138: 153-6.
182. Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997; 386: 493-5.
183. Emery CF, Hauck ER, Blumenthal JA. Exercise adherence or mamtenance among older adults: 1-year follow-up study. Psychol Aging 1992; 7: 466-70.
184. Hill RD, Storandt M, Malley M. The impact of Iong-term exercise training on psychological function in older adults. J Gerontol 1993; 48: P12-7.
185. Labbe EE, Welsh MC, Delaney D. Effects of consistent aerobic exercise on the psychological functioning of women. Percept Mot Skills 1988; 67: 919-25.
186. Morgun WP. Affective beneficence of vigorous physical activity. Med Sci Sports Exerc 1985; 17: 94-100.
187. Blomquist KB, Danner F. Effects of physical conditioning on information-processing efficiency. Percept Mot Skills 1987; 65: 175-86.
188. Raglin JS, Morgan WP. Influence of exercise and quiet rest on state anxiety and blood pressure. Med Sci Sports Exerc 1987; 19: 456-63.
189. Dishman RK. Medical psychology in exercise and sport. Med Clin North Am 1985; 69: 123-43.
190. De Coverly Veale DMW. Exercise and mental health. Acta Psychiatrica Scandinavica 1987; 76:113-120.
191. Fordyce DE, Wehner JM. Physical activity enhances spatial learning performance with an associated alteration in hippocampal protein kinase C activity in C57BL/6 and DBA/2 mice. Brain Res 1993; 619:111-9.
192. Greenwood BN, Foley TE, Day HE, Campisi J, Hammack, SH, Campeau S, et al. Freewheet running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J Neurosci 2003; 23: 2889-98.
193. Radak Z, Kaneko T, Tahara S, Nakamoto H, Pucsok, J, Sasvari M, et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int 2001; 38: 17-23.
194. Ramsden M, Berchtold NC, Patrick Kesslak J, Cotman CW, Pike, CL Exercise increases the vulnerability of rat hippocampal neurons to kainate lesion. Brain Res 2003; 971: 239-44.
195. Makatsori A, Duncko R, Schwendt M, Moncek F, Johansson, BB, Jezova D. Voluntary wheel running modulates glutamate receptor subunit gene expression and stress hormone release in Lewis rats. Psychoneuroendocrinology 2003; 28: 702-14.
196. Jacobs BL, Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000; 5: 262-9.
197. Neeper SA, Gomez-Pinilla F, Choi J, Cotman C. Exercise and brain neurotrophins. Nature 1995; 373: 109.
198. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996; 726: 49-56.
199. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002; 25: 295-301.
200. Tong L, Shen H, Perreau VM, Balazs R, Cotman, CW. Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis 2001; 8: 1046-56.
201. Molteni R, Wu A, Vaynman S, Ying Z, Bamard, RJ, Gomez-Pinilla F. Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brain-derived neurotrophic factor. Neuroscience 2004; 123: 429-40.
202. Molteni R, Ying Z, Gomez-Pinilla F. Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur J Neurosci 2002, 16: 1107-16.
203. Johnson RA, Mitchell GS. Exercise-induced changes in hippocampal brain-derived neurotrophic factor and neumtrophin-3: effects of rat strain. Brain Res 2003; 983: 108-14.
204. Johnson RA, Rhodes JS, Jeffrey SL, Garland T, Jr., Mitchell, GS. Hippocampal brain-derived neurotrophic factor but not neurotrophin-3 increases more in mice selected for increased voluntary wheel running. Neuroscience 2003; 121: 1-7.
205. Widenfalk J, Olsou L, Thoren P. Deprived of habitual running, rats downregulate BDNF and TrkB messages in the brain. Neurosci Res 1999; 34: 125-32.
206. Adlard PA, Cotman CW. Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience 2004; 124: 985-92.
207. Shen H, Tong L, Balazs R, Cotman CW. Physical activity elicits sustained activation of the cyclic AMP response element-binding protein anal mitogen-activated protein kinase in the rat hippocampus. Neuroscience 2001; 107: 219-29.
208. Vaynman S, Ying Z, Gomez-Pinilla F. Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience 2003; 122: 647-57.
209. Farmer J, Zhao X, van Praag H, Wodtke K, Gage, FH, Christie BR. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyms of adult male Sprague-Dawley rats in vivo. Neuroscience 2004; 124: 71-9.
210. Kempermann G. Why new neurons? Possible functions for adult hippocampal neurogenesis. J Neurosci 2002; 22: 635-8.
211. Pagliari R, Peyrin L. Norepinephrine release in the rat frontal cortex under treadmill exercise: a study with microdialysis. J Appl Physiol 1995; 78: 2121-30.
212. Pagliari R, Peyrin L. Physical conditioning in rats influences the central and peripheral catecholamine responses to sustained exercise. Eur J Appl Physiol Occup Physiol 1995; 71: 41-52.
213. Dunn AL, Reigle TG, Youngstedt SD, Annstrong RB, Dishman RK. Brain norepinephrine and metabolites after treadmill training and wheel running in rats. Med Sci Sports Exerc 1996; 28: 204-9.
214. Meeusen R, De Meirleir K. Exercise and brain neurotransmission. Sports Med 1995; 20: 160-88.
215. Samorajski T, Rolsten C, Przykorska A, Davis CM. Voluntary wheel running exercise and monoamine levels in brain, heart and adrenal glands of aging mice. Exp Gerontol 1987; 22:421-31.
216. Dishman RK. Brain monoamines, exercise, and behavioral stress: animal models. Med Sci Sports Exerc 1997; 29: 63-74.
217. Soares J, Holmes PV, Renner KJ, Edwards GL, Bunnell BN, Dishman RK. Brain noradrenergic responses to footshock after chronic activity-wheel running. Behav Neurosci 1999; 113: 558-66.
218. Yoo HS, Bunnell BN, Crabbe JB, Kalish LR, Dishman RK. Failure of neonatal clomipramine treatment to alter forced swim immobility: chronic treadmill or activity-wheel running and imipramine. Physiol Behav 2000; 70:407-11.
219. Aloyz R, Fawcett JP, Kaplan DR, Murphy RA, Miller FD. Activity-dependent activation of TrkB neurotrophin receptors in the adult. CNS Learn Mem 1999; 6: 216-31.
220. Zafra F, Lindholm D, Castren E, Hartikka J, Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor to RNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci 1992; 12: 4793-9.
221. Patterson SL, Grover LM, Schwartzkmin PA, Bothwell M. Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CAl evokes increases in BDNF and NT-3 mRNAs. Neuron 1992; 9: 1081-8.
222. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995; 270: 593-8.
223. Czurko A, Hirase H, Csicsvari J, Buzsaki G, Sustained activation of hippocampal pyramidal cells by 'space clamping' in a running wheel. Eur J Neurosci 1999; 11:344-52.
224. Oddie SD, Bland BH. Hippocampal formation theta activity and movement selection. Neurosci Biobehav Rev 1998; 22: 221-31.
225. Slawinska U, Kasicki S. The frequency of rat's hippocampal theta rhythm is related to the speed of locomotion. Brain Res 1998; 796: 327-3 I.
226. Ivy AS, Rodriguez FG, Garcia C, Chen MJ, Russo-Neustadt AA. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav 2003; 75: 81-8.
227. Garcia C, Chen MJ, Garza AA, Cotman CW, Russo-Neustadt A. The influence of specific noradrenergic and .serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 2003; 1 19: 721-32.
228. Metsis M, Timmusk T, Arenas E, Persson H. Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc Natl Acad Sci USA 1993; 90: 8802-6.
229. Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 1993; 10: 475-89.
230. Timmusk T, Persson H, Metsis M. Analysis of transcriptional initiation and translatability of brain-derived neurotrophic factor mRNAs in the rat brain. Neurosci Lett 1994; 177: 27-31.
231. Shelton RC. The combination of olanzapine and fluoxetine in mood disorders. Expert Opin Pharmacother 2003; 4:1175-83.
232. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60: 1079-88.
233. Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, et al. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001; 158: 131-4.
234. Pizzorusso T, Ratto GM, Putignano E, Maffei L. Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J Neurosci 2000; 20: 2809-16.
235. Heerssen HM, Segal RA. Location, location, Iocation: a spatial view of neurotrophin signal transduction. Trends Neurosci 2002; 25: 160-5.
236. Brunet A, Datta SR, Greenberg ME. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001; 11: 297-305.
237. Rodgers EE, Theibert AB. Functions of PI 3-kinase in development of the nervous system. Int J Dev Neurosci 2002; 20: 187-97.
238. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 2001; 11: 272-80.
239. Segal RA. Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 2003; 26: 299-330.
240. Behrens MM, Strasser U, Koh JY, Gwag BJ, Choi DW. Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: blockade of p38 mitogen-activated protein kinase. Neuroscience 1999; 94: 917-27.
241. Bhave SV, Ghoda L, Hoffman PL. Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. J Neurosci 1999; 19: 3277-86.
242. Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599-602.
243. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell 1997; 88: 435-7.
244. Filippa N, Sable CL, Filloux C, Hemmings B, Van Obberghen E. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol Cell Biol 1999; 19: 4989-5000.
245. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res 2000; 256: 34-41.
246. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: t 318-21.
247. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-68.
248. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 2000; 20: 8969-82.
249. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, et al. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999; 286: 1738-41.
250. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378: 785-9.
251. Cui H, Meng Y, Bulleit RF. Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells. Brain Res Dev Brain Res 1998; 111: 177-88.
252. Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, Heidenreich KA. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol 2000; 20: 9356-63.
253. Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, Mills GB. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 2000; 97:11960-5.
254. Ballou LM, Tian PY, Lin HY, Jiang YP, Lin RZ. Dual regulation of glycogen synthase kinase-3beta by the alphalA-adrenergic receptor. J Biol Chem 2001; 276: 40910-6.
255. Hetman M, Cavanaugh JE, Kimelman D, Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 2000; 20: 2567-74.
256. Crowder RI, Freeman RS. Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 2000; 275: 34266-71.
257. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000; 20: 4030-6.
258. Shaywitz AI, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68: 821-61.
259. Mowla SJ, Farhadi HF, Pareek S, Atwal JK, Morris SJ, Seidah NG, et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001; 276: 12660-6.
260. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996; 16: 2365-72.
261. Chen AC, Shirayama Y, Shin KH, Neve RL, Duman RS. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 2001; 49: 753-62.
262. Fujimaki K, Morinobu S, Duman RS. Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacology 2000; 22:42-51.
263. Nakagawa S, Kim JE, Lee R, Malberg JE, Chen J, Steffen C, et al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci, 2002; 22: 3673-82.
264. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. CREB: a major mediator of neuronal neurotrophin responses. Neuron 1997; 19:1031-47.
265. Van Hoomissen JD, Chambliss HO, Holmes PV, Dishman RK. Effects of chronic exercise and imipramine on mRNA for BDNF afier olfactory bulbectomy in rat. Brain Res 2003; 974: 228-35.
266. Dias BG, Banerjee SB, Duman RS, Vaidya VA. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 2003; 45: 553-63.
267. Altar CA, Whitehead RE, Chen R, Wortwein G, Madsen TM Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 2003; 54: 703-9.
268. Miro X, Perez-Torres S, Artigas F, Puigdomenech P, Palacios JM, Mengod G. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 2002; 43: 1148-57.
269. Garza AA, Ha TG, Garcia C, Chen MJ, Russo-Neustadt AA. Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol Biochem Behav 2004; 77: 209-20.
270. Zorner B, Wolfer DP, Brandis D, Kretz O, Zacher C, Madani R, et al. Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive". Biol Psychiatry 2003; 54: 972-82.
271. Chourbaji S, Hellweg R, Brandis D, Zomer B, Zacher C, Lang UE, et al. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 2004; 121: 28-36.
272. Marmigere F, Givalois L, Rage F, Arancibia S, Tapia-Arancibia L. Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 2003; 13: 646-55.
273. Nibuya M, Takahashi M, Russell DS, Duman RS. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 1999; 267: 81-4.
274. Givalois L, Marmigere F, Rage F, Ixart G, Arancibia S, Tapia-Arancibia L. Immobilization stress rapidly and differentially modulates BDNF and TrkB mRNA expression in the pituitary gland of adult male rats. Neuroendocrinology 2001; 74: 148-59.
275. Lang UE, Hellweg R, Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 2004; 29: 795-8.
276. Lang UE, Jockers-Scherubl MC, Hellweg R. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J Neural Transm 2004; 111:387-411.
277. Gould E, Tanapat P, Rydel T, Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 2000; 48: 715-20.
278. Lechin F, Van der Dijs B, Benaim M. Stress versus depression Prog Neuropsychopharmacol. Biol Psychiatry 1996; 20: 899-950.
279. Gertz H J, Kiefer M. Review about Ginkgo biloba special extract EGb 761 (Ginkgo). Curr Pharm Design 2004; 10(3): 261-4.
280. Nowak JZ, Zawilska JB. PACAP in avians: origin, occurrence, and receptors--pharmacological and functional considerations. Curr Pharm Design 2003; 9(6): 467-81.
281. Tanaka K, Ogawa N. Possibility of non-immunosuppressive immunophilin ligands as potential therapeutic agents for Parkinson's disease. Curr Pharm Design 2004; 10(6): 669-77.